Health care industry
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival
Precision Neuroscience’s Layer 7 Cortical Interface Courtesy of Precision Neuroscience Neurotech startup Precision Neuroscience on Thursday announced that a core component of its brain implant system has been approved by the U.S. Food and Drug Administration, a major win for the four-year-old company. Precision is building a brain-computer interface, or a BCI, which is a […]
Read More
UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers
The logo of UnitedHealth appears on the side of one of its office buildings in Santa Ana, California, on April 13, 2020. Mike Blake | Reuters UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in its privately run Medicare plans. Those bleak results from […]
Read More
23andMe bankruptcy under congressional investigation for customer data
Signage at 23andMe headquarters in Sunnyvale, California, U.S., on Wednesday, Jan. 27, 2021. David Paul Morris | Bloomberg | Getty Images The House Committee on Energy and Commerce is investigating 23andMe’s decision to file for Chapter 11 bankruptcy protection and has expressed concern that its sensitive genetic data is “at risk of being compromised,” CNBC has […]
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping Type 2 diabetes patients lower their blood sugar and body weight and showing safety on par with popular injections on the market. The trial results are among the pharmaceutical industry’s most closely watched studies […]
Read More
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled […]
Read More
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. Nurphoto | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
Medical product manufacturers are divided over Trump’s tariffs
President Donald Trump’s tariffs are creating a divide in the medical community. Medical devices and protective gear made in China, Mexico and Canada were exempt from duties during the first Trump administration, but so far have not gotten a reprieve from his newest round of levies. While device makers who would take a big hit […]
Read More
CDC says measles cases are most likely underreported as outbreak swells in Texas
Measles cases are most likely being underreported in the United States as public health officials scramble to find resources to address a ballooning outbreak in the Southwest, according to a senior scientist at the Centers for Disease Control and Prevention. So far this year, 747 cases have been recorded in the United States, according to […]
Read More
Pfizer scraps daily weight loss pill after liver injury in one patient
Nikos Pekiaridis | Lightrocket | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in […]
Read More